Filing Details
- Accession Number:
- 0001181431-13-025085
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2013-05-03 16:16:04
- Reporting Period:
- 2013-05-02
- Filing Date:
- 2013-05-03
- Accepted Time:
- 2013-05-03 16:16:04
- SEC Url:
- Form 4 Filing
Issuer
Cik | Name | Symbol | Sector (SIC) | IRS No |
---|---|---|---|---|
1108205 | Curis Inc | CRIS | Biological Products, (No Disgnostic Substances) (2836) | 043505116 |
Insiders
Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
---|---|---|---|---|---|---|---|
1190122 | Mark Noel | 4 Maguire Road Lexington MA 02421 | Vp, Tech Management | No | Yes | No | No |
Reported Non-Derivative Transactions
Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|---|---|---|---|---|---|
Common Stock | Acquisiton | 2013-05-02 | 52,258 | $2.43 | 79,798 | No | 4 | M | Direct | |
Common Stock | Disposition | 2013-05-02 | 52,258 | $3.66 | 27,540 | No | 4 | S | Direct | |
Common Stock | Acquisiton | 2013-05-02 | 17,742 | $2.43 | 45,282 | No | 4 | M | Direct | |
Common Stock | Disposition | 2013-05-02 | 17,742 | $3.66 | 27,540 | No | 4 | S | Direct |
Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|
No | 4 | M | Direct | |
No | 4 | S | Direct | |
No | 4 | M | Direct | |
No | 4 | S | Direct |
Reported Derivative Transactions
Sec. Name | Sec. Type | Acquisiton - Disposition | Date | Amount | Price | Amount - 2 | Price - 2 |
---|---|---|---|---|---|---|---|
Common Stock | Qualified stock option (right to buy) | Acquisiton | 2013-05-02 | 52,258 | $2.43 | 52,258 | $2.43 |
Common Stock | Nonqualified stock option (right to buy) | Acquisiton | 2013-05-02 | 17,742 | $2.43 | 17,742 | $2.43 |
Remaning Holdings | Exercise Date | Expiration Date | Equity Swap Involved | Transaction Form Type | Transaction Code | Nature of Ownership |
---|---|---|---|---|---|---|
0 | 2007-05-13 | 2013-05-13 | No | 4 | M | Direct |
0 | 2007-05-13 | 2013-05-13 | No | 4 | M | Direct |
Footnotes
- These shares were sold between $3.65-$3.70/share. The Company will provide, upon request, full information regarding the number of shares sold at each separate price.
- Options vested over a four-year period and became fully vested on May 13, 2007.